XCUR
Exicure, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.25
+1.63%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$19
- Revenue estimate
- $1.6M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$19
- Revenue actual
- —
- Revenue estimate
- $1.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +69.9%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026